The Technical Analyst
Venus Concept Inc [VERO]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Venus Concept Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.60% $0.844
America/New_York / 22 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 5.37 mill |
| EPS: | -6.84 |
| P/E: | -0.120 |
| Earnings Date: | May 15, 2024 |
| SharesOutstanding: | 6.36 mill |
| Avg Daily Volume: | 0.564 mill |
| RATING 2024-04-22 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.120 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.120 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.748 - 0.940 ( +/- 11.37%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-18 | Ew Healthcare Partners, L.p. | Buy | 0 | Secured Subordinated Convertible Notes |
| 2023-10-20 | Ew Healthcare Partners, L.p. | Buy | 502 513 | Senior Convertible Preferred Stock |
| 2023-10-04 | Madryn Asset Management, Lp | Buy | 248 755 | Series X Convertible Preferred Stock |
| 2023-10-04 | Madryn Asset Management, Lp | Sell | 0 | Secured Subordinated Convertible Notes |
| 2023-10-04 | Madryn Asset Management, Lp | Buy | 0 | Secured Subordinated Convertible Notes |
| INSIDER POWER |
|---|
| 96.45 |
| Last 85 transactions |
| Buy: 17 129 331 | Sell: 297 187 |
Forecast:
16:00 - $0.844
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.844
Forecast 2: 16:00 - $0.844
Forecast 3: 16:00 - $0.844
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.844 (3.60% ) |
| Volume | 0.0247 mill |
| Avg. Vol. | 0.564 mill |
| % of Avg. Vol | 4.38 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For VERO
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
VERO
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
Latest Press Releases
2024-04-15 07:30:00 - Press Release
Venus Concept To Release First Quarter Of Fiscal Year 2024 Financial Results On May 15, 2024
Toronto, april 15, 2024 (globe newswire) -- venus concept inc. (“venus concept” or the “company”) (nasdaq: vero), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2024 financial results will be released before the market opens on wednesday, may 15, 2024.
2024-04-08 07:30:00 - Press Release
Venus Concept Announces Israeli Regulatory Approval For Venus Bliss Max
Toronto, april 08, 2024 (globe newswire) -- venus concept inc. (“venus concept” or the “company”) (nasdaq: vero), a global medical aesthetic technology leader, today announced that it has received approval for the venus bliss max from the state of israel ministry of health. the venus bliss max was first launched commercially in the united states in q1 2022 after fda 510(k) clearance and offered internationally in approved jurisdictions.
2024-04-03 07:30:00 - Press Release
Venus Concept Announces Australian Regulatory Approval For Venus Versa Pro
Toronto, april 03, 2024 (globe newswire) -- venus concept inc. (“venus concept” or the “company”) (nasdaq: vero), a global medical aesthetic technology leader, today announced that it has therapeutic goods administration (tga) clearance in australia to market the venus versa pro system. the venus versa pro combines the applicator of the venus viva md with the venus versa system which are both approved in australia and registered in australian register of therapeutic goods (artg).
2024-04-01 07:00:00 - Press Release
Venus Concept Announces Fourth Quarter And Fiscal Year 2023 Financial Results
Toronto, april 01, 2024 (globe newswire) -- venus concept inc. (“venus concept” or the “company”) (nasdaq: vero), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended december 31, 2023.
2024-03-25 07:30:00 - Press Release
Venus Concept Granted Continued Listing From Nasdaq Hearings Panel, Subject To Return To Compliance With Nasdaq Listing Rules
Toronto, march 25, 2024 (globe newswire) -- venus concept inc. (“venus concept” or the “company”) (nasdaq: vero) announced today that it received a decision from the nasdaq hearings panel (the “nasdaq panel”) granting its request for continued listing on the nasdaq capital market, subject to the company demonstrating compliance with nasdaq listing rule 5550(b)(1) or any of the alternative requirements under nasdaq listing rule 5550(b) on or before may 28, 2024, and certain other conditions (the “panel decision”).
Latest News
2024-04-15 07:30:00 - GlobeNewsWire
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 15, 2024.
2024-02-20 07:30:00 - GlobeNewsWire
Venus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2023 financial results will be released before the market opens on Monday, April 1, 2024.
2023-12-20 10:31:39 - Zacks Investment Research
Venus Concept (VERO) Expands Global Reach With New Partnerships
Venus Concept (VERO) expects its deals to fetch continued success in both the United Kingdom and India.
2023-11-14 18:57:08 - Seeking Alpha
Venus Concept Inc. (VERO) Q3 2023 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q3 2023 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President & Chief Operating Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Sam Eiber - BTIG Operator Please standby. Good day, ladies and gentlemen.
2023-10-09 16:05:00 - GlobeNewsWire
Venus Concept to Release Third Quarter of Fiscal Year 2023 Financial Results on November 14, 2023
TORONTO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2023 financial results will be released after the market closes on Tuesday, November 14, 2023.
2023-08-14 22:44:09 - Seeking Alpha
Venus Concept Inc. (VERO) Q2 2023 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q2 2023 Earnings Conference Call August 14, 2023 5:00 PM ET Company Participants Rajiv De Silva – Chief Executive Officer Hemanth Varghese – President and Chief Innovation and Business Officer Domenic Della Penna – Chief Financial Officer Conference Call Participants Jeff Cohen – Ladenburg Thalmann Marie Thibault – BTIG Anthony Vendetti – Maxim Group Operator Good day, ladies and gentlemen. Welcome to the Second Quarter 2023 Earnings Conference Call for Venus Concept.
2023-07-05 16:05:00 - GlobeNewsWire
Venus Concept to Release Second Quarter of Fiscal Year 2023 Financial Results on August 14, 2023
TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2023 financial results will be released after the market closes on Monday, August 14, 2023.
2023-05-15 10:07:04 - Seeking Alpha
Venus Concept Inc. (VERO) Q1 2023 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q1 2023 Earnings Conference Call May 15, 2023 8:00 AM ET Company Participants Rajiv De Silva - CEO Hemanth Varghese - President & Chief Innovation and Business Officer Domenic Della Penna - CFO Conference Call Participants Destiny Hance - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2023 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.
2023-04-11 07:30:00 - GlobeNewsWire
Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023
TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15, 2023.
2023-03-27 13:11:10 - Seeking Alpha
Venus Concept Inc. (VERO) Q4 2022 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Innovation and Business Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Anthony Vendetti - Maxim Group Jeffrey Cohen - Ladenburg Thalmann Operator Good day ladies and gentlemen and welcome to the Fourth Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.